Search research articles
Contact Us
Filters
Showing results (51-60 of 250) with videos related to
Page
of 25
Sort By:
Cell Regulation
|
October 1, 1990
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix
R Ishai-Michaeli, A Eldor, I Vlodavsky
European Journal of Haematology
|
January 1, 1995
Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia
S Gillis, E J Dann, A Eldor
Thrombosis Research
|
March 1, 1980
Antifibrinolytic activity of human saliva components
H Haze, A Eldor, A A Garfunkel
European Journal of Clinical Pharmacology
|
January 1, 1984
The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man
A Eldor, E Zylber-Katz, M Levy
The Journal of Clinical Investigation
|
October 1, 1989
Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties
R Bar-Shavit, A Eldor, I Vlodavsky
The New England Journal of Medicine
|
May 4, 1978
Treatment of diabetic necrobiosis with aspirin and dipyridamole
A Eldor, E G Diaz, E Naparstek
Thrombosis Research
|
August 1, 1980
Heparin-prostacyclin interactions: heparin does not modify the prostacyclin induced relaxation of coronary vasculature
A Eldor, G Allan, B B Weksler
Blood Reviews
|
June 1, 1993
The changing course of thrombotic thrombocytopenic purpura and modern therapy
M Rose, J M Rowe, A Eldor
Thrombosis Research
|
April 1, 1980
Antifibrinolytic activity of human saliva components
H Haze, A Eldor, A A Garfunkel
Acta Haematologica
|
January 1, 1994
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group
D Ben-Yehuda, S Gillis, A Eldor
Page
of 25
Search research articles
Search
Showing results (51-60 of 250) with videos related to
Sort By:
Page
of 25
Cell Regulation
|
October 1, 1990
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix
R Ishai-Michaeli, A Eldor, I Vlodavsky
European Journal of Haematology
|
January 1, 1995
Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia
S Gillis, E J Dann, A Eldor
Thrombosis Research
|
March 1, 1980
Antifibrinolytic activity of human saliva components
H Haze, A Eldor, A A Garfunkel
European Journal of Clinical Pharmacology
|
January 1, 1984
The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man
A Eldor, E Zylber-Katz, M Levy
The Journal of Clinical Investigation
|
October 1, 1989
Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties
R Bar-Shavit, A Eldor, I Vlodavsky
The New England Journal of Medicine
|
May 4, 1978
Treatment of diabetic necrobiosis with aspirin and dipyridamole
A Eldor, E G Diaz, E Naparstek
Thrombosis Research
|
August 1, 1980
Heparin-prostacyclin interactions: heparin does not modify the prostacyclin induced relaxation of coronary vasculature
A Eldor, G Allan, B B Weksler
Blood Reviews
|
June 1, 1993
The changing course of thrombotic thrombocytopenic purpura and modern therapy
M Rose, J M Rowe, A Eldor
Thrombosis Research
|
April 1, 1980
Antifibrinolytic activity of human saliva components
H Haze, A Eldor, A A Garfunkel
Acta Haematologica
|
January 1, 1994
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group
D Ben-Yehuda, S Gillis, A Eldor
Page
of 25